Patent Assignment
Reel/Frame 047069/0309
Assignment of Assignor's Interest
Recorded: 2018-10-04
Pages: 14
Assignee
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
4311 11TH AVENUE NE, SUITE 500, SEATTLE, WASHINGTON, 98105-4608
Covered Properties
(3)
Modulation of IRE1
PCT:
PCT/US2013/062039 ↗
Substituted Imidazo[1,5-a]Pyrazines for Modulation of IRE1
Substituted Imidazolopyrazine Compounds and Methods of Using Same
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Sep 22, 2014
From: UNIVERSITY OF WASHINGTON / CENTER FOR COMMERCIALIZATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033783/0866 →
Confirmatory License
Aug 27, 2015
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036484/0879 →
Assignment of Assignor's Interest
Oct 4, 2018
From: OAKES, SCOTT A.; PAPA, FEROZ R.; WANG, LIKUN; BACKES, BRADLEY J.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 047069/0041 →